Nearly 50% of patients with chronic diseases do not properly adhere to their prescribed treatment plan1. So how can we curb a phenomenon that puts the health – and sometimes the lives – of patients at risk? To draw attention to this issue, the World Heart Federation, together with Servier and 14 partner institutions, is launching the first-ever World Adherence Day this Thursday, March 27. Let’s take a closer look at this major public health challenge and a unique initiative!
Commit in the #DontMissAMoment campaign
Throughout the world, patient adherence is dangerously low. In high-income countries, estimates indicate that more than half of patients with chronic diseases do not follow their prescribed treatments. In low-income countries, adherence rates are even lower. That’s why, along with the World Heart Federation, we are launching a call to action to address this crisis. The goal is to raise awareness of the importance of therapeutic adherence: acting today to protect tomorrow.
80%
A patient is considered “non-adherent” if they comply with less than 80% of their prescribed treatment plan.
The #DontMissAMoment campaign emphasizes the importance of carefully following your treatment plan to the letter, whether it involves medication and/or a healthier lifestyle. For patients, this means prioritizing health and well-being, as well as having more opportunities to create meaningful moments with loved ones.
Servier takes up the challenge of therapeutic adherence
In recent years, adherence to prescribed treatment for chronic conditions has become a major concern in the health care sector. And yet, this phenomenon is still underestimated by public authorities, despite its undeniable impact on the sustainability of health care systems. Fortunately, awareness is gradually growing across the board (patients and their loved ones, public authorities, industry, etc.).
Politico, an international political news media, has partnered with Servier to launch a series of exclusive interviews to shed light on this complex topic and offer innovative solutions. Explore the interviews.
At Servier, we take this reality very seriously. As the world’s fifth leading pharmaceutical group in cardiology and the leading group in hypertension2, we firmly believe that therapeutic adherence is a vital component when it comes to treating patients and improving their care. We place particular emphasis on three key areas:
Our “As One” initiative also exemplifies this approach. It is designed to improve patient adherence and control, enhance outcomes, and strive for better therapeutic efficacy. We aim to provide better care for both health care professionals and patients.
“True to our corporate mission — committed to therapeutic progress to serve patients — we are actively working to address all factors that can improve patient adherence to treatment. This is a fundamental issue for any patient with a chronic disease.”
Therapeutic adherence: When every pill counts
Simplified treatments, digital tools, and stakeholder awareness are key factors in overcoming this global health concern.